-+ 0.00%
-+ 0.00%
-+ 0.00%

DataMeds AI unit Helomics wins Humana Medicaid coverage for ChemoFx gynecologic cancer assay

PUBT·10/12/2026 10:02:08
DataMeds AI unit Helomics wins Humana Medicaid coverage for ChemoFx gynecologic cancer assay
  • DataMeds AI’s Helomics unit secured Medicaid coverage under Humana policy for its ChemoFx chemoresponse assay in gynecologic cancers.
  • Coverage took effect July 22, 2026 under Humana policy HUM-SC-2240-003, billed under CPT codes 81535 and 81536.
  • Eligibility centers on select clinical scenarios, including recurrence or treatment-refractory disease, supporting potential volume growth for Helomics’ CLIA lab.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610120600ACCESSWRNAPR_____1235643) on October 12, 2026, and is solely responsible for the information contained therein.